On ECHEMI
Home > Drugs > NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.
NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.
  • Founded in:

    1989-01-25
  • Country:

    China China
  • Address:

    No. 8 Kunming Lake Street, Shenyang Economic and Technological Development Zone
  • Tax NO.:

    91210106242656694M
  • Registered Funds:

    80 million yuan
  • Website:

  • Email:

Related Drugs
Bacillus licheniformis live bacteria granules
Each bag of this product contains no less than 250 million live bacteria of Bacillus licheniformis. The auxiliary materials are lactose, mannitol, stevioside, tartrazine and polyvinyl pyrrolidone.
Name Description Content CAS NO. Registered Holders
BACILLUSLICHENIFORMIS

250 millionPieces/bag 68038-66-4 0
Lactose

63-42-3 27
Mannitol

87-78-5 31
Stevioside

57817-89-7 22
Tartrazine

1934-21-0 0
Polyvinylpyrrolidone

9003-39-8 18
Bacillus licheniformis live bacteria granules
Each bag of this product contains no less than 250 million live bacteria of Bacillus licheniformis. The auxiliary materials are lactose, mannitol, stevioside, tartrazine and polyvinyl pyrrolidone.
Name Description Content CAS NO. Registered Holders
BACILLUSLICHENIFORMIS

It has an antagonistic effect on pathogenic bacteria such as Staphylococcus aureus and yeast-like bacteria, promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, adjusts the imbalance of bacterial flora, prompts the body to produce antibacterial active substances, kills pathogenic bacteria, and causes intestinal hypoxia through the oxygen-depriving biological effect, which is conducive to the growth of a large number of anaerobic bacteria.

More

It has an antagonistic effect on pathogenic bacteria such as Staphylococcus aureus and yeast-like bacteria, promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, adjusts the imbalance of bacterial flora, prompts the body to produce antibacterial active substances, kills pathogenic bacteria, and causes intestinal hypoxia through the oxygen-depriving biological effect, which is conducive to the growth of a large number of anaerobic bacteria.

250 millionPieces/bag 68038-66-4 0
Lactose

After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria.

More

After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria.

63-42-3 27
Mannitol

After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria.

More

After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria.

87-78-5 31
Stevioside

After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria.

More

After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria.

57817-89-7 22
Tartrazine

After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria.

More

After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria.

1934-21-0 0
Polyvinylpyrrolidone

After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria.

More

After the live bacteria enter the intestine, this product has an antagonistic effect on pathogenic bacteria such as Staphylococcus and yeast-like bacteria, and promotes the growth of Bifidobacterium, Lactobacillus, Bacteroides, and Peptostreptococcus, thereby adjusting the imbalance of flora to achieve the purpose of treatment. This product can promote the body to produce antibacterial active substances and kill pathogenic bacteria. In addition, the oxygen-depriving biological effect causes intestinal hypoxia, which is conducive to the growth of a large number of anaerobic bacteria.

9003-39-8 18
L-Carnitine Oral Solution
The main ingredient of this product is L-carnitine.
Name Description Content CAS NO. Registered Holders
L-carnitine

It is a natural substance in the body that is necessary for mammalian energy metabolism. Its main function is to promote lipid metabolism. It can bring long-chain fatty acids into the mitochondrial matrix and promote their oxidative decomposition to provide energy for cells, and it can also export short-chain fatty acyl groups produced in mitochondria. Supplementation of this product can alleviate fat metabolism disorders and dysfunction of skeletal muscle, myocardial and other tissues caused by its deficiency in the body.

More

It is a natural substance in the body that is necessary for mammalian energy metabolism. Its main function is to promote lipid metabolism. It can bring long-chain fatty acids into the mitochondrial matrix and promote their oxidative decomposition to provide energy for cells, and it can also export short-chain fatty acyl groups produced in mitochondria. Supplementation of this product can alleviate fat metabolism disorders and dysfunction of skeletal muscle, myocardial and other tissues caused by its deficiency in the body.

541-15-1 17
Amsacrine
Name Description Content CAS NO. Registered Holders
Amsacrine

Unspecified

More

Unspecified

51264-14-3 4
Amsacrine Injection
The main ingredient is N-[4-(9-acridinylamino)-3-methoxyphenyl-methylsulfonamide.
Name Description Content CAS NO. Registered Holders
Amsacrine hydrochloride

Amsacrine has a broad spectrum of anti-tumor activity, and its mechanism of action is similar to that of anthracyclines. Amsacrine binds to DNA and affects the pairing of adenine and thymine base pairs. It mainly inhibits DNA synthesis, and has a more obvious inhibitory effect on cells in the S and G2 phases, but has less effect on RNA synthesis.

More

Amsacrine has a broad spectrum of anti-tumor activity, and its mechanism of action is similar to that of anthracyclines. Amsacrine binds to DNA and affects the pairing of adenine and thymine base pairs. It mainly inhibits DNA synthesis, and has a more obvious inhibitory effect on cells in the S and G2 phases, but has less effect on RNA synthesis.

54301-15-4 0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.